7UOH image
Entry Detail
PDB ID:
7UOH
Keywords:
TRANSFERASE
Title:
PRMT5/MEP50 crystal structure with MTA and an achiral, class 1, non-atropisomeric inhibitor bound
Biological Source:
Source Organism:
Homo sapiens
Host Organism:
Spodoptera frugiperda
PDB Version:
Deposition Date:
2022-04-12
Release Date:
2022-08-17
Method Details:
Experimental Method:
X-RAY DIFFRACTION
Resolution:
2.70 Å
R-Value Free:
0.23
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
I 2 2 2
7UOH validation report
Macromolecular Entities
Protein Blast
Polymer Type:polypeptide(L)
Description:Protein arginine N-methyltransferase 5
Chain IDs:A
Chain Length:645
Number of Molecules:1
Biological Source:Homo sapiens
UniProt ID:O14744 Pfam ID:PF17285, PF05185, PF17286 EC:2.1.1.320
Protein Blast
Polymer Type:polypeptide(L)
Description:Methylosome protein 50
Chain IDs:B
Chain Length:350
Number of Molecules:1
Biological Source:Homo sapiens
UniProt ID:Q9BQA1 Pfam ID:PF00400 EC:2.1.1.320
Ligand Molecules
MTA
NXF
Primary Citation
Design and evaluation of achiral, non-atropisomeric 4-(aminomethyl)phthalazin-1(2H)-one derivatives as novel PRMT5/MTA inhibitors.
Bioorg.Med.Chem. 71 116947 116947 (2022)
PMID: 35926325 DOI: 10.1016/j.bmc.2022.116947

Abstact

MRTX1719 is an inhibitor of the PRMT5/MTA complex and recently entered clinical trials for the treatment of MTAP-deleted cancers. MRTX1719 is a class 3 atropisomeric compound that requires a chiral synthesis or a chiral separation step in its preparation. Here, we report the SAR and medicinal chemistry design strategy, supported by structural insights from X-ray crystallography, to discover a class 1 atropisomeric compound from the same series that does not require a chiral synthesis or a chiral separation step in its preparation.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
7UOH